首页> 外国专利> Acetaminophen, following oral ingift tilvejebringerhurtigt onset of therapeutic action

Acetaminophen, following oral ingift tilvejebringerhurtigt onset of therapeutic action

机译:口服对乙酰氨基酚治疗后开始对乙酰氨基酚的治疗作用

摘要

A gelatin capsule for oral administration comprises a gelatin shell substantially encapsulating a physiologically compatible fill material, the fill material comprising an effective dosage amount of acetaminophen, a vehicle for the acetaminophen, a surfactant and a modifier for the vehicle, characterised in that:- (a) the vehicle comprises a low molecular weight polyethylene glycol having an average molecular weight of from about 400 to 1000 and a higher molecular weight polyethylene glycol having an average molecular weight of from about 1000 to about 10000, the acetaminophen being substantially evenly distributed through the vehicle; (b) the surfactant is of a type that is physiologically solubile and is in solution in the vehicle; and (c) the viscosity modifier is present in an amount equal to or greater than the amount necessary to gel the vehicle.
机译:用于口服的明胶胶囊包括基本上包封生理相容性填充材料的明胶壳,所述填充材料包含有效剂量的对乙酰氨基酚,对乙酰氨基酚的媒介物,表面活性剂和所述媒介物的改性剂,其特征在于:-( a)载剂包含平均分子量为约400至1000的低分子量聚乙二醇和平均分子量为约1000至约10000的较高分子量聚乙二醇,对乙酰氨基酚基本上均匀地分布在车辆; (b)表面活性剂是生理上可溶的并且在车辆中的溶液中的类型; (c)粘度调节剂的存在量等于或大于使载体胶凝所需的量。

著录项

  • 公开/公告号DK456485A

    专利类型

  • 公开/公告日1985-10-07

    原文格式PDF

  • 申请/专利权人 SCHERER CORPORATION R. P.;

    申请/专利号DK19850004564

  • 发明设计人 ROGERS JR. A. GARNELL;

    申请日1985-10-07

  • 分类号A61K;

  • 国家 DK

  • 入库时间 2022-08-22 08:16:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号